首页> 美国卫生研究院文献>Technology in Cancer Research Treatment >Limitations of PET/CT in the Detection of Occult N1 Metastasis in Clinical Stage I(T1-2aN0) Non-Small Cell Lung Cancer for Staging Prior to Stereotactic Body Radiotherapy
【2h】

Limitations of PET/CT in the Detection of Occult N1 Metastasis in Clinical Stage I(T1-2aN0) Non-Small Cell Lung Cancer for Staging Prior to Stereotactic Body Radiotherapy

机译:PET / CT在立体定向身体放疗前分期I(T1-2aN0)临床非小细胞肺癌分期中检测隐匿性N1转移的局限性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Purpose/Objectives:Patients receiving stereotactic body radiotherapy for stage I non-small cell lung cancer are typically staged clinically with positron emission tomography–computed tomography. Currently, limited data exist for the detection of occult hilar/peribronchial (N1) disease. We hypothesize that positron emission tomography–computed tomography underestimates spread of cancer to N1 lymph nodes and that future stereotactic body radiotherapy patients may benefit from increased pathologic evaluation of N1 nodal stations in addition to N2 nodes.
机译:目的/目的:I期非小细胞肺癌接受立体定向放射治疗的患者通常在临床上采用正电子发射断层扫描-计算机断层扫描进行分期。目前,用于隐性肺门/支气管肺炎(N1)疾病检测的数据有限。我们假设,正电子发射断层扫描-计算机断层扫描低估了癌症向N1淋巴结的扩散,未来的立体定向放疗患者可能会从N1淋巴结和N2淋巴结的病理评估中受益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号